Feinberg Peter 4
4 · Immuneering Corp · Filed Jun 23, 2022
Insider Transaction Report
Form 4
Immuneering CorpIMRX
Feinberg Peter
Director
Transactions
- Award
Stock Option
2022-06-21+14,200→ 14,200 totalExercise: $4.63Exp: 2032-06-20→ Class A Common Stock (14,200 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in equal monthly installments over a one-year period commencing on July 21, 2022, and will be fully vested and exercisable on June 21, 2023, or the date of the 2023 annual meeting of stockholders, whichever comes first.